Free Trial

Manhattan Bridge Capital (LOAN) News Today

$5.27
0.00 (0.00%)
(As of 05/28/2024 ET)
Manhattan Bridge Capital Inc.
Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) Sees Large Growth in Short Interest
Manhattan Bridge Capital, Inc. (NASDAQ:LOAN - Get Free Report) saw a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 28,800 shares, a growth of 35.2% from the March 15th total of 21,300 shares. Currently, 0.3% of the company's stock are sold short. Based on an average trading volume of 21,000 shares, the short-interest ratio is presently 1.4 days.
Manhattan Bridge Capital (NASDAQ:LOAN) Receives New Coverage from Analysts at StockNews.com
StockNews.com started coverage on Manhattan Bridge Capital in a research report on Wednesday. They set a "strong-buy" rating for the company.
Manhattan Bridge Capital, Inc. Declares Quarterly Dividend of $0.12 (NASDAQ:LOAN)
Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) announced a quarterly dividend on Wednesday, March 13th. Shareholders of record on Wednesday, July 10th will be paid a dividend of 0.115 per share by the credit services provider on Monday, July 15th. This represents a $0.46 dividend on an annualized basis and a yield of 9.66%. The ex-dividend date is Wednesday, July 10th.
Manhattan Bridge Capital, Inc. (LOAN)
Manhattan Bridge Capital (NASDAQ:LOAN) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on Manhattan Bridge Capital in a research note on Thursday. They set a "strong-buy" rating for the company.
Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) Holdings Boosted by Hardy Reed LLC
Hardy Reed LLC increased its position in Manhattan Bridge Capital, Inc. (NASDAQ:LOAN - Free Report) by 871.6% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 332,296 shares of the credit services provider's stock after purchasing an additional 298,096 shar
StockNews.com Begins Coverage on Manhattan Bridge Capital (NASDAQ:LOAN)
StockNews.com initiated coverage on Manhattan Bridge Capital in a research note on Saturday. They set a "strong-buy" rating for the company.
Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc LOAN
Buy Rating Issued on THIS 10% Yield Stock
BridgeBio Pharma Announces $250 Million Private Placement Equity Financing
Get Manhattan Bridge Capital News Delivered to You Automatically

Sign up to receive the latest news and ratings for LOAN and its competitors with MarketBeat's FREE daily newsletter.

You won't believe what Citigroup just did to it's depositors (Ad)

The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...

CLICK HERE TO GET YOUR GUIDE NOW

LOAN Media Mentions By Week

LOAN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LOAN
News Sentiment

1.19

0.72

Average
Finance
News Sentiment

LOAN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LOAN Articles
This Week

3

1

LOAN Articles
Average Week

Get Manhattan Bridge Capital News Delivered to You Automatically

Sign up to receive the latest news and ratings for LOAN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:LOAN) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners